BSE NSE
MARKET ANALYSIS NEWS CORPORATE INFORMATION CORPORATE ACTIONS OTHER MARKETS
Your Result on : Company News Details
Indo US Bio-Tech Ltd Industry :  Miscellaneous
BSE Code
541304
ISIN Demat
INE250Z01010
Book Value (Rs)
31.294634
NSE Symbol
N.A
Divident Yield %
0
Market Cap
(Rs In Cr.)
433
P/E (TTM)
52.38
EPS (TTM)
4.12
Face Value
(Rs)
10
Back
Indo US Bio-Tech standalone net profit declines 81.23% in the March 2024 quarter
03-May-24   Hrs IST

Net profit of Indo US Bio-Tech declined 81.23% to Rs 0.52 crore in the quarter ended March 2024 as against Rs 2.77 crore during the previous quarter ended March 2023. Sales declined 12.92% to Rs 15.77 crore in the quarter ended March 2024 as against Rs 18.11 crore during the previous quarter ended March 2023.

For the full year,net profit rose 13.95% to Rs 8.25 crore in the year ended March 2024 as against Rs 7.24 crore during the previous year ended March 2023. Sales rose 17.98% to Rs 72.84 crore in the year ended March 2024 as against Rs 61.74 crore during the previous year ended March 2023.

ParticularsQuarter EndedYear Ended
 Mar. 2024Mar. 2023% Var.Mar. 2024Mar. 2023% Var.
Sales15.7718.11 -13 72.8461.74 18
OPM %6.2117.06 -14.8315.19 -
PBDT0.832.84 -71 9.618.22 17
PBT0.632.63 -76 8.817.39 19
NP0.522.77 -81 8.257.24 14

Risk Factor   |   Terms & Conditions   |   Privacy Policy   |   Disclaimer   |  Sitemap 
Important Links:   SEBI   |   NSE   |   BSE   |   MCX   |   NCDEX   |   NSDL   |   CDSL  |   FMC
SMS FINANCIAL SERVICES P. LTD -NSE SEBI No. AP1413004363 | BSE SEBI No. AP01091801121968
2017-18 © SMS Financial Services. All rights reserved. Designed, developed & powered by C-MOTS Infotech (ISO 9001:2015 certified)